In this Issue:
Mechanisms by which drug-free platelets promote platelet aggregation during antiplatelet therapy
Inhibitor development in non-severe haemophilia
Neutrophil to lymphocyte ratio and risk of a first episode of stroke in AF patients
Risk of CVD is decreased among VWD patients
Distinguishing between anti–PF4/heparin antibodies that can and cannot cause HIT
Platelet-derived VWF fosters ischaemic stroke injury in mice
Prothrombin is a powerful modifier of multiorgan pathologies in SCD mice
Platelets and PAR-4 contribute to APAP-induced liver injury in mice
Abnormalities in FLI1 causative of Paris-Trousseau thrombocytopenia
Effect of oral iron supplements on hepcidin and its effects on subsequent iron absorption
Please login below to download this issue (PDF)